Transplantation-related morbidity and complications
| Patients (n)/ patients at risk | Prevalence | Median time after transplantation (years) | |
| Reoperation | 20/63 | 31.7% | |
| <24 hour | 18/20 | 90.0% | |
| 24 hours to 1 week | 2/20 | 10.0% | |
| Treated rejection within 1 year | 27/56 | 48.2% | 20 (12.8–78.8) |
| Patients alive at 1 year post-transplantation | 54/63 | 85.7% | |
| Malignancy | 12/54 | 22.2% | 8.7 (6.6–13.5) |
| Skin | 5/12 | 41.7% | 11.1 (8.4–18.3) |
| Lymphoma | 5/12 | 41.7% | 8.9 (0.6–18.3) |
| Other | 2/12 | 16.6% | 6.7 |
| Hypertension requiring medical treatment | 29/56 | 51.8% | 0.6 (0.2–1.2) |
| Renal insufficiency | 24/56 | 42.9% | 1.0 (0.3–7.7) |
| Dialysis | 9/24 | 37.5% | 11.4 (4.8–13.1) |
| Transplantation | 4/24 | 16.7% | 16.6 (13.6–18.3) |
| Cardiac allograft vasculopathy | 6/54 | 11.1% | 6.6 (6.0–12.5) |
| ISLHT Grade 1 | 1/6 | 16.7% | 6.5 |
| ISLHT Grade 2 | 3/6 | 50% | 6.2 |
| ISLHT Grade 3 | 2/6 | 33.3% | 13.4 |
| Bronchiolitis obliterans syndrome | 23/54 | 36.5% | 2.3 (1.2–7.5) |
Values are presented as numbers, percentages or as median (IQR).
ISLHT, International Society for Heart and Lung Transplantation.